Find Sulodexide manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

NDC API

NDC API

0

VMF

NDC API

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Adenosine, n-methyl-2'-o-methyl-, 57821-29-1, A903628, N6-methyl-2'-o-methyladenosine:(2r,3r,4r,5r)-2-(hydroxymethyl)-4-methoxy-5-(6-(methylamino)-9h-purin-9-yl)tetrahydrofuran-3-ol
Molecular Formula
C12H17N5O4
Molecular Weight
295.29  g/mol
InChI Key
GRYSXUXXBDSYRT-UHFFFAOYSA-N

Sulodexide
1 2D Structure

Sulodexide

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-(hydroxymethyl)-4-methoxy-5-[6-(methylamino)purin-9-yl]oxolan-3-ol
2.1.2 InChI
InChI=1S/C12H17N5O4/c1-13-10-7-11(15-4-14-10)17(5-16-7)12-9(20-2)8(19)6(3-18)21-12/h4-6,8-9,12,18-19H,3H2,1-2H3,(H,13,14,15)
2.1.3 InChI Key
GRYSXUXXBDSYRT-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CNC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)OC
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. Adenosine, N-methyl-2'-o-methyl-

2. 57821-29-1

3. A903628

4. N6-methyl-2'-o-methyladenosine:(2r,3r,4r,5r)-2-(hydroxymethyl)-4-methoxy-5-(6-(methylamino)-9h-purin-9-yl)tetrahydrofuran-3-ol

2.3 Create Date
2007-02-09
3 Chemical and Physical Properties
Molecular Weight 295.29 g/mol
Molecular Formula C12H17N5O4
XLogP30.2
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count8
Rotatable Bond Count4
Exact Mass295.12805404 g/mol
Monoisotopic Mass295.12805404 g/mol
Topological Polar Surface Area115 Ų
Heavy Atom Count21
Formal Charge0
Complexity363
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count4
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

API SUPPLIERS

read-more
read-more

01

Opocrin SpA

Italy

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BOS Manchester
Not Confirmed
arrow

Opocrin SpA

Italy

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BOS Manchester
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

02

Enomark

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BOS Manchester
Not Confirmed
arrow

Enomark

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BOS Manchester
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

03

Alfasigma

Italy

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BOS Manchester
Not Confirmed
arrow

Alfasigma

Italy

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BOS Manchester
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF arrow-down VMF Others AUDIT
blank

04

Biofer

Italy

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BOS Manchester
Not Confirmed
arrow

Biofer

Italy

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BOS Manchester
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF arrow-down VMF Others AUDIT
blank

05

Laboratori Derivati Organici

Italy

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BOS Manchester
Not Confirmed
arrow

Laboratori Derivati Organici

Italy

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BOS Manchester
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

06

Alfasigma

Italy

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BOS Manchester
Not Confirmed
arrow

Alfasigma

Italy

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BOS Manchester
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF arrow-down VMF Others AUDIT
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-moreread-more

01

Opocrin Laboratorio

Italy

USDMF

arrow
BOS Manchester
Not Confirmed

01

BOS Manchester
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 14874

Submission : 2000-05-10

Status : Inactive

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

Enomark

India
CPhI India
Not Confirmed
arrow

Enomark

India
arrow
CPhI India
Not Confirmed

Sulodexide

About the Company : ENOMARK Group of Companies stands as a prominent Contract Manufacturer, boasting a cutting-edge manufacturing facility in Ahmadabad (Gujarat) that complies with WHO-GMP standards. ...

ENOMARK Group of Companies stands as a prominent Contract Manufacturer, boasting a cutting-edge manufacturing facility in Ahmadabad (Gujarat) that complies with WHO-GMP standards. ENOMARK is known for its extensive product portfolio, which includes Tablets, Capsules, Dry Syrups, Protein Powders, Soft Gelatin Capsules, Gummy Candy, Liquid Orals, Oral Spray, Effervescent Tablets, Sachets and Oil.
blank

02

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

Sulodexide

About the Company : Since its establishment in 1960 LDO has oriented its productions towards the extraction of active pharmaceutical ingredients from animal organs. Over the years, LDO has specialized...

Since its establishment in 1960 LDO has oriented its productions towards the extraction of active pharmaceutical ingredients from animal organs. Over the years, LDO has specialized in the production of Heparin, Heparinoids and Glycosaminoglycans(Mucopolysaccharides), along with a production of antianemic iron derivatives.Thanks to its extensive knowledge in the extraction and purification processes of active pharmaceutic ingredients – gained in decades of production and research – LDO is today one of the leading players in the production of Glycosaminoglycans (Mucopolysaccharides), exporting its products globally.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more
  • Development Update

Details:

Sulodexide is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of COVID-19.


Lead Product(s): Sulodexide,Inapplicable

Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Miscellaneous

Sponsor: Alfasigma

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable May 12, 2022

blank

01

Centro Medico del Noroeste

Country
arrow
CPhI India
Not Confirmed

Centro Medico del Noroeste

Country
arrow
CPhI India
Not Confirmed

Details : Sulodexide is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of COVID-19.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

May 12, 2022

blank
  • Development Update

Details:

Vessel (Sulodexide) is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Vascular Diseases.


Lead Product(s): Sulodexide,Inapplicable

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Vessel

Study Phase: Phase IIIProduct Type: Miscellaneous

Sponsor: Alfasigma

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable August 13, 2021

blank

02

Value Outcomes Ltd.

Country
arrow
CPhI India
Not Confirmed

Value Outcomes Ltd.

Country
arrow
CPhI India
Not Confirmed

Details : Vessel (Sulodexide) is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Vascular Diseases.

Product Name : Vessel

Product Type : Miscellaneous

Upfront Cash : Inapplicable

August 13, 2021

blank

Details:

Sulodexide is a Other Small Molecule drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of COVID-19.


Lead Product(s): Sulodexide,Inapplicable

Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed

Study Phase: Phase II/ Phase IIIProduct Type: Miscellaneous

Sponsor: Clinedem

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable July 23, 2020

blank

03

Alfasigma

Italy
arrow
CPhI India
Not Confirmed

Alfasigma

Italy
arrow
CPhI India
Not Confirmed

Details : Sulodexide is a Other Small Molecule drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of COVID-19.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

July 23, 2020

blank

Details:

Sulodexide is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Peripheral Arterial Disease.


Lead Product(s): Sulodexide,Atorvastatin,Aspirin Lysinate,Captopril

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Miscellaneous

Sponsor: Poseidon CRO

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable December 12, 2017

blank

04

Alfasigma

Italy
arrow
CPhI India
Not Confirmed

Alfasigma

Italy
arrow
CPhI India
Not Confirmed

Details : Sulodexide is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Peripheral Arterial Disease.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

December 12, 2017

blank
  • Development Update

Details:

Sulodexide is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Postthrombotic Syndrome.


Lead Product(s): Sulodexide,Inapplicable

Therapeutic Area: Hematology Brand Name: Undisclosed

Study Phase: Phase IVProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable July 31, 2015

blank

05

Bama GeVe, S.L.U.

Country
arrow
CPhI India
Not Confirmed

Bama GeVe, S.L.U.

Country
arrow
CPhI India
Not Confirmed

Details : Sulodexide is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Postthrombotic Syndrome.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

July 31, 2015

blank
  • Development Update

Details:

Sulodexide is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Diabetic Nephropathies.


Lead Product(s): Sulodexide,Inapplicable

Therapeutic Area: Nephrology Brand Name: Undisclosed

Study Phase: Phase IVProduct Type: Miscellaneous

Sponsor: ALFA WASSERMANN(BJ) Market Research and Management Co., Ltd

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable March 16, 2011

blank

06

Sun Yat-sen University

Country
arrow
CPhI India
Not Confirmed

Sun Yat-sen University

Country
arrow
CPhI India
Not Confirmed

Lead Product(s) : Sulodexide,Inapplicable

Therapeutic Area : Nephrology

Highest Development Status : Phase IV

Partner/Sponsor/Collaborator : ALFA WASSERMANN(BJ) Market Research and Management Co., Ltd

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Sulodexide is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Diabetic Nephropathies.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

March 16, 2011

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

read-more
read-more

01

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

sulodexide

Brand Name : Vessel

Dosage Form :

Dosage Strength : 50 Cps 250 Uls  

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

02

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

sulodexide

Brand Name : Vessel

Dosage Form :

Dosage Strength : 10 Vials Im Ev 600 Uls/2 Ml  

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

03

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

Sulodexide

Brand Name : Aterina

Dosage Form : Soft Capsule

Dosage Strength : 15MG

Packaging :

Approval Date : 1982-07-01

Application Number : 55545

Regulatory Info : Authorized

Registration Country : Spain

blank

04

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

Sulodexide

Brand Name : Aterina

Dosage Form : Injectable Solution

Dosage Strength : 60MG

Packaging :

Approval Date : 2018-01-15

Application Number : 82783

Regulatory Info : Authorized

Registration Country : Spain

blank

05

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

Sulodexide

Brand Name : Dovida

Dosage Form : Soft Capsule

Dosage Strength : 30MG

Packaging :

Approval Date : 2014-07-14

Application Number : 78901

Regulatory Info : Suspensed

Registration Country : Spain

blank

06

SINCLAIR Srl

Country
CPhI India
Not Confirmed
arrow

SINCLAIR Srl

Country
arrow
CPhI India
Not Confirmed

sulodexide

Brand Name : Provenal

Dosage Form :

Dosage Strength : 50 Cps 250 Uls  

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

07

FARMAC.CABER SpA

Country
CPhI India
Not Confirmed
arrow

FARMAC.CABER SpA

Country
arrow
CPhI India
Not Confirmed

sulodexide

Brand Name : Ravenol F

Dosage Form :

Dosage Strength : 50 Cps 250 Uls  

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

08

MITIM Srl

Country
CPhI India
Not Confirmed
arrow

MITIM Srl

Country
arrow
CPhI India
Not Confirmed

sulodexide

Brand Name : Angioflux

Dosage Form :

Dosage Strength : 50 Cps 250 Usl  

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

09

OMIKRON ITALIA Srl

Country
CPhI India
Not Confirmed
arrow

OMIKRON ITALIA Srl

Country
arrow
CPhI India
Not Confirmed

sulodexide

Brand Name : Treparin

Dosage Form :

Dosage Strength : 50 Cps 250 Lru  

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

10

ALFA BIOTECH Srl

Country
CPhI India
Not Confirmed
arrow

ALFA BIOTECH Srl

Country
arrow
CPhI India
Not Confirmed

sulodexide

Brand Name : Clarens

Dosage Form :

Dosage Strength : 50 Cps 250 Uls  

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

APIs

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Looking for 57821-29-1 / Sulodexide API manufacturers, exporters & distributors?

Sulodexide manufacturers, exporters & distributors 1

60

PharmaCompass offers a list of Sulodexide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sulodexide manufacturer or Sulodexide supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sulodexide manufacturer or Sulodexide supplier.

PharmaCompass also assists you with knowing the Sulodexide API Price utilized in the formulation of products. Sulodexide API Price is not always fixed or binding as the Sulodexide Price is obtained through a variety of data sources. The Sulodexide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Sulodexide

Synonyms

Adenosine, n-methyl-2'-o-methyl-, 57821-29-1, A903628, N6-methyl-2'-o-methyladenosine:(2r,3r,4r,5r)-2-(hydroxymethyl)-4-methoxy-5-(6-(methylamino)-9h-purin-9-yl)tetrahydrofuran-3-ol

Cas Number

57821-29-1

Sulodexide Manufacturers

A Sulodexide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sulodexide, including repackagers and relabelers. The FDA regulates Sulodexide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sulodexide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Sulodexide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Sulodexide Suppliers

A Sulodexide supplier is an individual or a company that provides Sulodexide active pharmaceutical ingredient (API) or Sulodexide finished formulations upon request. The Sulodexide suppliers may include Sulodexide API manufacturers, exporters, distributors and traders.

click here to find a list of Sulodexide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Sulodexide USDMF

A Sulodexide DMF (Drug Master File) is a document detailing the whole manufacturing process of Sulodexide active pharmaceutical ingredient (API) in detail. Different forms of Sulodexide DMFs exist exist since differing nations have different regulations, such as Sulodexide USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Sulodexide DMF submitted to regulatory agencies in the US is known as a USDMF. Sulodexide USDMF includes data on Sulodexide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sulodexide USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Sulodexide suppliers with USDMF on PharmaCompass.

Sulodexide KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Sulodexide Drug Master File in Korea (Sulodexide KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Sulodexide. The MFDS reviews the Sulodexide KDMF as part of the drug registration process and uses the information provided in the Sulodexide KDMF to evaluate the safety and efficacy of the drug.

After submitting a Sulodexide KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Sulodexide API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Sulodexide suppliers with KDMF on PharmaCompass.

Sulodexide GMP

Sulodexide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Sulodexide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sulodexide GMP manufacturer or Sulodexide GMP API supplier for your needs.

Sulodexide CoA

A Sulodexide CoA (Certificate of Analysis) is a formal document that attests to Sulodexide's compliance with Sulodexide specifications and serves as a tool for batch-level quality control.

Sulodexide CoA mostly includes findings from lab analyses of a specific batch. For each Sulodexide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Sulodexide may be tested according to a variety of international standards, such as European Pharmacopoeia (Sulodexide EP), Sulodexide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sulodexide USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty